Skip to main content

Table 2 Allowable uses for publicly purchased antivirals (n = 31).

From: Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California

Allowable Use n (% of LHDs)
Treatment of ill persons 28 (90)
Post-Exposure Prophylaxis (PEP) 24 (77)
Pre-Exposure Prophylaxis (PrEP) 7 (23)
Allowable use determined by dispensing site 8 (26)
Other 2 (6)
  1. Among the thirty-one local health departments (LHDs) reporting that publicly purchased antivirals were dispensed in their community, Table 2 summarizes the number and proportion of LHDs that allowed publicly purchased antivirals to be used for treatment, post-exposure prophylaxis, and pre-exposure prophylaxis